Zealand Pharma A/S
Zealand Pharma's GHG Emissions Data Preview
In 2025, Zealand Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Zealand Pharma has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature.  a | 0000000 |
Location-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature.  a | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 |
a
a
a
a
a
a
a
aVerified Sources Behind Zealand Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zealand Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Zealand Pharma's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Zealand Pharma amounted to 140 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Zealand Pharma decreased by 29.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
Zealand Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Zealand Pharma's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Zealand Pharma were 72 metric tons of CO₂ equivalent (tCO₂e).a
Has Zealand Pharma reduced its Scope 1 emissions over time?
Since 2023, Zealand Pharma's Scope 1 emissions have decreased by 50%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2024), Zealand Pharma's Scope 1 emissions decreased by 45.04%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are Zealand Pharma's Scope 2 emissions?
In 2025, Zealand Pharma reported Scope 2 greenhouse gas (GHG) emissions of 154 tCO₂e using the market-based method and 68 tCO₂e using the location-based method.a
Has Zealand Pharma reduced its Scope 2 emissions over time?
Since 2023, Zealand Pharma's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 59.28%, reflecting a declining long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2024), Zealand Pharma's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Zealand Pharma's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does Zealand Pharma use for Scope 2 reporting?
In 2025, Zealand Pharma reported its Scope 2 emissions using the market-based method and using the location-based method.a
Zealand Pharma's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Zealand Pharma's Value Chain Emissions
In 2025, Zealand Pharma reported 413,991 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Zealand Pharma includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
Zealand Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Zealand Pharma's Scope 3 emissions?
In 2025, Zealand Pharma reported total Scope 3 emissions of 413,991 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 8.46% of these emissions originated from upstream activities such as purchased goods and capital goods, while 91.54% came from downstream activities like product use, distribution, and end-of-life treatment.a
Has Zealand Pharma reduced its Scope 3 emissions over time?
Since 2023, Zealand Pharma's Scope 3 emissions have increased by 205.35%, reflecting a rising long-term trend in Scope 3 emissions over time.a
Compared to the previous year (2024), Zealand Pharma's Scope 3 emissions increased by 35.81%, suggesting that the company faced challenges in reducing emissions across its value chain.a
What categories of Scope 3 emissions does Zealand Pharma disclose?
In 2025, Zealand Pharma reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Zealand Pharma's Scope 3 emissions?
In 2025, the largest contributors to Zealand Pharma's Scope 3 emissions were:a
- Investments (Cat. 15): 378,977 tCO₂e (91.54%)
- Purchased Goods and Services (Cat. 1): 28,756 tCO₂e (6.95%)
- Upstream Transportation and Distribution (Cat. 4): 3,975 tCO₂e (0.96%)
Zealand Pharma's Scope 3 Emissions by Categories
Insights into Zealand Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Zealand Pharma reported Scope 1 greenhouse gas (GHG) emissions of 72 tCO₂e and total revenues of USD 1,452 millions. This translates into an emissions intensity of 0.05 tCO₂e per millions USD.a
Zealand Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Zealand Pharma's GHG emissions intensity compare to its peers?
In 2025, Zealand Pharma reported a Scope 1 emissions intensity of 0.05 tCO₂e per millions USD. Compared to the peer group median of 3.8, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Zealand Pharma rank on GHG emissions intensity within its industry?
In 2025, Zealand Pharma ranked 4 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Zealand Pharma among the top performers, with one of the lowest emissions intensities relative to peers.a
Insights into Zealand Pharma's Total Carbon Footprint
In 2025, Zealand Pharma reported a total carbon footprint of 414,131 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 35.77% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Zealand Pharma's total carbon footprint was Scope 3 emissions, accounting for 99.97% of the company's total carbon footprint, followed by Scope 1 emissions at 0.02%.a